|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 35/74 | |
| A61P 3/04 | |||
| A61P 3/10 | |||
| A61P 9/00 | |||
| A61P 29/00 | |||
| A61P 31/12 | |||
| A61K 35/747 | |||
| A61K 35/745 | |||
| A23L 33/135 |
| (11) | Number of the document | 2808024 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14179491.7 |
| Date of filing the European patent application | 2010-06-18 | |
| (97) | Date of publication of the European application | 2014-12-03 |
| (45) | Date of publication and mention of the grant of the patent | 2019-04-24 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 218563 P | 2009-06-19 | US |
| (72) |
Burcelin, Rémy, FR
Carcano, Didier, FR
Lahtinen, Sampo, FI
|
| (73) |
DuPont Nutrition Biosciences ApS,
Langebrogade 1, 1411 Copenhagen K,
DK
|
| (54) | Bifidobacteria for treating congestive heart failure |
| Bifidobacteria for treating congestive heart failure |